BMRA · Biomerica Inc · Financials
$2.36
-0.01 (-0.42%)
At close · Sep 17
Going-concern doubt
— flagged Aug 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about our ability to continue as a going concern. Our future viability depends on the successful execution of our strategic plans, securing additional financing, and achieving profitable operations.”View the 10-K filed Aug 31, 2026
Market Cap
$10.42M
Shares
4.59M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$4.45M
-16.2%
FY2026
Net Income
-$3.78M
+24.1%
FY2026
Gross Margin
8.13%
-1.2pp
FY2026
Operating Margin
-119.47%
-22.8pp
FY2026
Diluted EPS
-$1.30
+39.8%
FY2026
Operating Cash Flow
-$3.42M
+11%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $4.45M | $5.31M | $5.42M | $5.34M | $18.87M | $7.2M | $6.69M | $5.2M | $5.56M | $5.79M | $5.14M | $4.96M | $5.12M | $6.47M | $6.08M | $4.9M | |
| $1.23M | $165K | $431K | $133K | — | — | — | — | — | — | — | — | — | — | — | — | |
| $4.09M | $4.81M | $4.8M | $4.89M | $15.89M | $6.83M | $4.95M | $3.91M | $3.81M | $3.77M | $3.62M | $3.42M | $3.45M | $4.05M | $3.78M | $3.37M | |
| $362K | $498K | $611K | $446K | $2.98M | $366.29K | $1.74M | $1.29M | $1.75M | $2.02M | $1.52M | $1.54M | $1.67M | $2.43M | $2.3M | $1.53M | |
| 8.13% | 9.38% | 11.28% | 8.35% | 15.78% | 5.09% | 25.97% | 24.84% | 31.53% | 34.91% | 29.65% | 31.07% | 32.6% | 37.51% | 37.78% | 31.14% | |
| $788K | $1.02M | $1.49M | $1.58M | $1.81M | $2.19M | $1.93M | $1.68M | $1.4M | $1.13M | $780.33K | $733.64K | $589.87K | $459.09K | $347.13K | $420.57K | |
| $1.67M | $1.63M | $2.34M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $3.23M | $2.98M | $3.15M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $4.89M | $4.61M | $5.49M | $6.09M | $5.7M | $5.67M | $2.55M | $2.03M | $1.84M | $1.85M | $1.57M | $1.48M | $1.53M | $1.45M | $1.45M | $1.24M | |
| $20K | $21K | $18K | $18K | $239K | $34K | $23.87K | $61.69K | $75.55K | $74.33K | $76.14K | $75.06K | $29.52K | $29.38K | $32.83K | — | |
| $77K | $87K | $81K | $84K | $339K | $105K | $105.3K | $101.22K | $111.06K | $144.89K | $156.28K | $178.22K | $177.52K | $187.33K | $147.3K | $130.05K | |
| $5.68M | $5.64M | $6.98M | $7.67M | $7.51M | $7.87M | $4.48M | $3.7M | $3.24M | $2.98M | $2.35M | $2.21M | $2.12M | $1.91M | $1.79M | $1.66M | |
| -$5.32M | -$5.14M | -$6.37M | -$7.22M | -$4.53M | -$7.5M | -$2.74M | -$2.41M | -$1.48M | -$954.63K | -$826.95K | -$670.6K | -$446.59K | $514.01K | $505K | -$132.26K | |
| -119.47% | -96.72% | -117.58% | -135.29% | -24.03% | -104.18% | -40.95% | -46.39% | -26.63% | -16.48% | -16.09% | -13.51% | -8.72% | 7.94% | 8.3% | -2.7% | |
| -$5.24M | -$5.05M | -$6.29M | -$7.14M | -$4.2M | -$7.39M | -$2.64M | -$2.31M | -$1.37M | -$809.75K | -$670.67K | -$492.38K | -$269.08K | $701.33K | $652.3K | -$2215 | |
| — | — | — | — | — | $367 | $9 | $47 | $37 | $282 | $167 | — | $142 | $302 | $1585 | $5830 | |
| $1.57M | $165K | $431K | $134K | $27K | $66.5K | $71.18K | $43.97K | $47.73K | $46.07K | $30.97K | $24.16K | $20.17K | $10.46K | $108.45K | $291.71K | |
| -$3.75M | -$4.97M | -$5.94M | -$7.09M | -$4.51M | -$7.43M | -$2.67M | -$2.37M | -$1.43M | -$908.56K | -$795.99K | -$646.43K | -$426.42K | $524.46K | $613.45K | — | |
| $23K | $1000 | $42K | $51K | $24K | $13.06K | $7390 | $24.24K | $31.8K | — | $703.8K | -$315.02K | -$210.76K | -$12.49K | $65.01K | $1999 | |
| -$3.78M | -$4.97M | -$5.98M | -$7.14M | -$4.53M | -$7.45M | -$2.68M | -$2.39M | -$1.47M | -$908.56K | -$1.5M | -$331.41K | -$215.66K | $536.96K | $548.44K | $157.45K | |
| -84.77% | -93.64% | -110.4% | -133.73% | -24.01% | -103.43% | -40% | -46.01% | -26.34% | -15.69% | -29.18% | -6.68% | -4.21% | 8.3% | 9.02% | 3.21% | |
| -$3.78M | -$4.98M | -$5.97M | -$7.18M | -$4.56M | -$7.45M | -$2.68M | -$2.4M | -$1.48M | -$910.81K | -$1.5M | -$333.53K | -$216.8K | $533.98K | $546.87K | $156.5K | |
| USD/shares | -$1.30 | -$2.16 | -$2.84 | -$4.00 | -$2.88 | -$4.96 | -$2.08 | -$2.08 | -$1.36 | -$0.88 | -$1.60 | -$0.32 | -$0.24 | $0.64 | $0.64 | $0.16 |
| USD/shares | -$1.30 | -$2.16 | -$2.84 | -$4.00 | -$2.88 | -$4.96 | -$2.08 | -$2.08 | -$1.36 | -$0.88 | -$1.60 | -$0.32 | -$0.24 | $0.56 | $0.64 | $0.16 |
| shares | 2.91M | 2.3M | 2.1M | 1.77M | 1.58M | 1.49M | 1.27M | 1.15M | 1.07M | 1.04M | 953.26K | 944.03K | 921.35K | 878.05K | 860.99K | — |
| shares | 2.91M | 2.3M | 2.1M | 1.77M | 1.58M | 1.49M | 1.27M | 1.15M | 1.07M | 1.04M | 953.26K | 944.03K | 921.35K | 931.39K | 888.47K | 838.04K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 0.83×
EV/EBIT
—
P/E (TTM)
—
Peer median 6.19×
Peer medians compare against the 65 similar-size Medical Devices companies (of 144 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2022 | FY2021 |
|---|---|---|
| Physicians Office | $14,259,000 | $2,801,000 |
| Clinical Lab | $3,064,000 | $3,077,000 |
| Over the Counter | $1,089,000 | $766,000 |
| Contract Manufacturing | $459,000 | $555,000 |
By Geography (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| North America | $1,466,000 | $1,658,000 | $1,285,000 | $1,470,000 | $997,000 |
| Asia | $1,409,000 | $1,718,000 | $1,881,000 | $2,021,000 | $13,375,000 |
| Europe | $1,117,000 | $1,297,000 | $1,438,000 | $1,798,000 | $4,339,000 |
| Middle East | $446,000 | $630,000 | $800,000 | $39,000 | $70,000 |
| South America | $15,000 | $8,000 | $11,000 | $11,000 | $90,000 |
By Product & Service (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Clinical Lab | $2,732,000 | $3,181,000 | $3,236,000 | $3,310,000 | $3,064,000 |
| Contract Manufacturing | $891,000 | $1,070,000 | $741,000 | $610,000 | $459,000 |
| Over the Counte | $821,000 | $1,049,000 | $1,426,000 | $1,169,000 | $1,089,000 |
| Physicians Office | $9,000 | $11,000 | $12,000 | $250,000 | $14,259,000 |